Fontolizumab
Fontolizumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Fontolizumab (marketed under the trade name HuZAF™) is a humanized monoclonal antibody which is used as an immunosuppressive drug to treat Crohn's disease.
Trade Name | Fontolizumab |
Generic | Fontolizumab |
Fontolizumab Other Names | Fontolizumab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in crohn's disease and psoriasis and psoriatic disorders.
How Fontolizumab works
Fontolizumab is a humanised antibody directed against recombinant human IFN-{gamma}. The antibody binds to natural human IFN-{gamma} and inhibits expression of IFN-{gamma} regulated genes known to be upregulated in Crohn’s disease.
Innovators Monograph
You find simplified version here Fontolizumab